Uterine Serous Carcinoma

• CLINICAL_TRIALS research · 2026-04-15
  Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. [Phase 1]

  A Phase 1 trial evaluating escalating doses of the investigational agent BMS-986463 to assess safety, tolerability, and early signals of act…

• CLINICAL_TRIALS trial_result · 2026-03-18
  Clinical Trial Update: A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma [Phase 2]

  Phase 2 study of Azenosertib (ZN-c3) in women with recurrent or persistent uterine serous carcinoma has completed.

• CLINICAL_TRIALS research · 2026-03-02
  Clinical Trial Update: Azenosertib in Uterine Serous Carcinoma: Biomarker Study [Phase 2]

  Phase 2 biomarker study of Azenosertib in uterine serous carcinoma is currently recruiting.

• CLINICAL_TRIALS trial_result · 2025-11-04
  Clinical Trial Update: A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer [Phase 1, Phase 2]

  Phase I/II study evaluating VLS-1488 in adults with advanced cancer; the trial is currently recruiting across multiple solid-tumor indicatio…

• CLINICAL_TRIALS research · 2025-10-09
  Clinical Trial Update: A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma [Phase 2]

  A Phase II trial evaluating afatinib for persistent or recurrent HER2-positive uterine serous carcinoma, currently recruiting.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-08-19
  Clinical Trial Update: Trial of Maintenance With Niraparib- Uterine Serous Carcinoma [Phase 2]

  Phase 2 study of Niraparib as maintenance therapy in uterine serous carcinoma and related endometrial cancers has completed.

• CLINICAL_TRIALS trial_result · 2025-02-13
  Clinical Trial Update: Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1]

  A Phase 1 trial evaluates the combination of mirvetuximab soravtansine and rucaparib camsylate in patients with recurrent gynecologic cancer…

• CLINICAL_TRIALS trial_result · 2023-08-14
  Clinical Trial Update: A Study of Adavosertib as Treatment for Uterine Serous Carcinoma [Phase 2]

  Phase 2 trial investigating adavosertib for uterine serous carcinoma has completed with results posted.

• CLINICAL_TRIALS trial_result · 2023-04-18
  Clinical Trial Update: Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer [Phase 2]

  Phase 2 trial evaluating carboplatin/paclitaxel with or without trastuzumab in uterine serous/endometrial cancer completed; results posted i…